Treating Insomnia in Mild Cognitive Impairment

Purpose

The goal of this study is to test a new way to improve sleep quality in persons living with mild cognitive impairment. The treatment combines a safe and gentle way to stimulate the brain, called transcranial magnetic stimulation, with a psychological treatment, called cognitive behavioral therapy for insomnia.

Conditions

  • Mild Cognitive Impairment (MCI)
  • Insomnia

Eligibility

Eligible Ages
Over 65 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Aged 65 years or older - Speak and read English - Clinical diagnosis of MCI - Reported insomnia symptoms (sleep-onset and/or sleep maintenance) that cause significant distress or impairment in social, occupational, or other areas of functioning over the past three months - Have access to an Internet-enabled computer or tablet at home, or ability to connect a BIDMC-provided tablet to the internet, with private space to complete cognitive testing - Capable of and willing to provide written informed consent

Exclusion Criteria

  • Evidence of significant cognitive impairment or dementia - Contraindications for TMS or MRI - Current psychological treatment for insomnia - Uncontrolled moderate-to-severe obstructive sleep apnea or other untreated sleep disorder (e.g., Restless Leg Syndrome, Periodic Limb Movement Disorder, parasomnia). - Diagnosis of Parkinson's disease, Huntington's disease, Lewy-Body disease, or other neurological condition known to impact sleep - Current diagnosis of major psychiatric disorder (well-controlled depression or anxiety is permitted) - Current opiate/opioid use - Alcohol or drug abuse within the past year - Irregular sleep schedule (bedtime before 8pm/after 2am OR wake time before 4am/after 10am), unless participant states they are willing and able to change if prompted.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Intervention Model Description
This study will test the combination of neuromodulation by repetitive transcranial magnetic stimulation (rTMS) with cognitive behavioral therapy for insomnia (CBT-I). All participants will receive the active intervention. Participants will be randomized to receive one or two treatments of rTMS per day.
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
One (1) TMS treatment per day plus CBT-I
One (1) daily treatment of intermittent theta-burst stimulation (iTBS) applied to the left dorsolateral prefrontal cortex (L-DLPFC) for 10 days (2 weeks) followed by a 9-week Internet-delivered cognitive behavioral therapy for insomnia (CBT-I) program
  • Device: Transcranial Magnetic Stimulation (TMS) therapy
    Each treatment consists of 600 TMS pulses (~3 minutes) applied to the L-DLPFC
    Other names:
    • Intermittent theta-burst stimulation (iTBS)
  • Behavioral: Cognitive behavioral therapy for insomnia (CBT-I)
    9-week fully-automated, Internet-delivered CBT-I program: SHUTi OASIS (Sleep Healthy Using the Internet for Older Adult Sufferers of Insomnia and Sleeplessness)
    Other names:
    • SHUTi OASIS
Active Comparator
Two (2) TMS treatments per day plus CBT-I
Two (2) daily treatments, spaced 1 hour apart, of intermittent theta-burst stimulation (iTBS) applied to the left dorsolateral prefrontal cortex (L-DLPFC) for 10 days (2 weeks) followed by a 9-week Internet-delivered cognitive behavioral therapy for insomnia (CBT-I) program
  • Device: Transcranial Magnetic Stimulation (TMS) therapy
    Each treatment consists of 600 TMS pulses (~3 minutes) applied to the L-DLPFC
    Other names:
    • Intermittent theta-burst stimulation (iTBS)
  • Behavioral: Cognitive behavioral therapy for insomnia (CBT-I)
    9-week fully-automated, Internet-delivered CBT-I program: SHUTi OASIS (Sleep Healthy Using the Internet for Older Adult Sufferers of Insomnia and Sleeplessness)
    Other names:
    • SHUTi OASIS

Recruiting Locations

Beth Israel Deaconess Medical Center
Boston 4930956, Massachusetts 6254926 02215
Contact:
Alex Clinical Research Coordinator
617-667-0386
adiamon2@bidmc.harvard.edu

More Details

NCT ID
NCT06687161
Status
Recruiting
Sponsor
Beth Israel Deaconess Medical Center

Study Contact

Alex Clinical Research Coordinator
617-667-0386
adiamon2@bidmc.harvard.edu